Vaccines Against Pneumonia
Clinics in Chest Medicine · 2026-06 · 47 (2) · 399-417
DOI: 10.1016/j.ccm.2025.12.019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Chest Medicine, 2026-06. Verfasst von Madelyn Renzetti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Albert Einstein College of Medicine, Yale University, New Haven, CT, USA. Hauptthemen laut MEDLINE: Pneumonia. Die Arbeit nennt 76 Literaturangaben.
Abstract (Originalsprache)
Pneumonia is one of the global leading causes of mortality and impacts all age groups. Both viruses and bacteria can contribute to the development of lower respiratory tract infections and incidences of each vary in different age groups and immune statuses. Vaccines exist to target many of the pathogens associated with pneumonia including influenza, COVID-19, respiratory syncytial virus, pneumococcal pneumonia, pertussis, and Haemophilus influenzae type b. Vaccinations have demonstrated positive effects at reducing rates of infection and hospitalizations related to pneumonia. However, vaccination rates remain low and barriers including vaccine hesitancy exist among the general population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Albert Einstein College of Medicine, Yale University, New Haven, CT, USA.
- Department of Internal Medicine, Yale University, New Haven, CT, USA. Electronic address: Ashley.losier@yale.edu.
Zitieren
APA
Renzetti, M., & Losier, A. (2026). Vaccines Against Pneumonia. Clinics in Chest Medicine, 47(2), 399-417. https://doi.org/10.1016/j.ccm.2025.12.019
Vancouver
Renzetti M, Losier A. Vaccines Against Pneumonia. Clinics in Chest Medicine. 2026;47(2):399-417. doi:10.1016/j.ccm.2025.12.019
BibTeX
@article{Renzetti2026,
author = {Renzetti, Madelyn and Losier, Ashley},
title = {Vaccines Against Pneumonia},
journal = {Clinics in Chest Medicine},
year = {2026},
volume = {47},
number = {2},
pages = {399--417},
doi = {10.1016/j.ccm.2025.12.019}
}
EUVIMED